Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
出版年份 2023 全文链接
标题
Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
作者
关键词
-
出版物
CURRENT OPINION IN RHEUMATOLOGY
Volume 35, Issue 3, Pages 175-184
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-02-08
DOI
10.1097/bor.0000000000000930
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
- (2022) Kathleen MM Vanni et al. RMD Open
- COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
- (2022) Michael Putman et al. Lancet Rheumatology
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
- (2022) Tommy Nyberg et al. LANCET
- Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset
- (2022) Gregory McDermott et al. RHEUMATOLOGY
- Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey
- (2022) Lisa G Rider et al. RHEUMATOLOGY
- COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis
- (2022) René Cordtz et al. RHEUMATOLOGY
- Assessing the Severity of COVID‐19 Lung Injury in Rheumatic Diseases versus the General Population Using Deep Learning‐Derived Chest Radiograph Scores
- (2022) Naomi J. Patel et al. ARTHRITIS CARE & RESEARCH
- SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry
- (2022) Jean Liew et al. RMD Open
- Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis
- (2022) Jessica Widdifield et al. Lancet Rheumatology
- Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases
- (2022) Julie J. Paik et al. CURRENT OPINION IN PHARMACOLOGY
- Plasma biomarkers for systemic inflammation in COVID‐19 survivors
- (2022) Juan Zhao et al. Proteomics Clinical Applications
- DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
- (2022) Michael Di Iorio et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Breakthrough SARS‐CoV‐2 infections in immune mediated disease patients undergoing B cell depleting therapy: A retrospective cohort analysis
- (2022) Cassandra M Calabrese et al. Arthritis & Rheumatology
- Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
- (2022) Zara Izadi et al. Lancet Rheumatology
- Factors Associated with COVID-19 Breakthrough Infection Among Vaccinated Patients with Rheumatic Diseases: A Cohort Study
- (2022) Naomi J. Patel et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Risk of COVID ‐19 among unvaccinated and vaccinated patients with rheumatoid arthritis: a general population study
- (2022) Hui Li et al. ARTHRITIS CARE & RESEARCH
- Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity
- (2022) Cassandra Calabrese et al. RMD Open
- Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
- (2022) Michael DiIorio et al. RMD Open
- Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
- (2022) Gabriel Figueroa-Parra et al. Lancet Rheumatology
- Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases
- (2022) Naomi J Patel et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)
- (2022) Namrata Singh et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease
- (2021) Kristin M D’Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
- (2021) Hannah Bower et al. ANNALS OF THE RHEUMATIC DISEASES
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2021) Anja Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 vaccination and antirheumatic therapy
- (2021) Jack Arnold et al. RHEUMATOLOGY
- Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals
- (2021) Bryant R. England et al. Arthritis & Rheumatology
- Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
- (2021) Parakkal Deepak et al. ANNALS OF INTERNAL MEDICINE
- Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases
- (2021) Claire Cook et al. ANNALS OF THE RHEUMATIC DISEASES
- Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
- (2021) Jeffrey A Sparks et al. ANNALS OF THE RHEUMATIC DISEASES
- New-onset IgG autoantibodies in hospitalized patients with COVID-19
- (2021) Sarah Esther Chang et al. Nature Communications
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- (2021) Sandra Lopez-Leon et al. Scientific Reports
- Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
- (2021) Amy D. Proal et al. Frontiers in Microbiology
- Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
- (2021) Paulina Kaplonek et al. Science Immunology
- Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
- (2021) Sebastian Eduardo Sattui et al. RMD Open
- Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
- (2021) Tiffany Y-T Hsu et al. Lancet Rheumatology
- Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study
- (2021) Jeffrey R. Curtis et al. JOURNAL OF RHEUMATOLOGY
- A clinical case definition of post-COVID-19 condition by a Delphi consensus
- (2021) Joan B Soriano et al. LANCET INFECTIOUS DISEASES
- Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study
- (2021) Erjia Ge et al. PLoS One
- Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States
- (2021) Rahul Raiker et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Increased risk of COVID ‐19 in patients with rheumatoid arthritis: a general population‐based cohort study
- (2021) Yilun Wang et al. ARTHRITIS CARE & RESEARCH
- Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US
- (2021) Jing Sun et al. JAMA Internal Medicine
- SARS‐CoV ‐2 Infection and COVID ‐19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta‐Analysis
- (2021) Richard Conway et al. Arthritis & Rheumatology
- Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
- (2021) Zara Izadi et al. JAMA Network Open
- Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
- (2021) Hannah Bower et al. RMD Open
- Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
- (2021) Ingrid Jyssum et al. Lancet Rheumatology
- Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases
- (2021) Jonathan S Hausmann et al. Lancet Rheumatology
- Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
- (2020) Kristin M D’Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
- (2020) Naomi Serling-Boyd et al. ANNALS OF THE RHEUMATIC DISEASES
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID‐19 Outcomes in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs) Compared to the General Population: A US Multi‐Center Comparative Cohort Study
- (2020) Kristin M. D’Silva et al. Arthritis & Rheumatology
- Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry
- (2020) Milena A. Gianfrancesco et al. Arthritis & Rheumatology
- Rheumatoid Arthritis
- (2019) Jeffrey A. Sparks ANNALS OF INTERNAL MEDICINE
- Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017
- (2019) Saeid Safiri et al. ANNALS OF THE RHEUMATIC DISEASES
- MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
- (2018) Pierre-Antoine Juge et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search